Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ae5e5a0650195ddcc018f4ec329e6aba http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f6008280051be718f08e7783ba1b5d03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4754e881853e78db40ceb25dec57008e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e4902348df23becacb5859738dd28fc |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-35 |
filingDate |
2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fefaa3f78f6fba61015d19ad96eb2cb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aad7645d988a35e7234f7edb1c5924d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_165b39c2425b494a7d3736577c5af54a |
publicationDate |
2009-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009070118-A1 |
titleOfInvention |
Novel wheat allergens |
abstract |
The present invention relates to the field of IgE-mediated allergy, particularly occupational asthma such as baker s asthma. More specifically the invention relates to the identification of a novel wheat allergen and the use thereof in therapy and diagnosis of IgE-mediated allergy. Furthermore the present invention provides the use of known peptides and proteins in therapy and diagnosis. The invention also relates to methods for diagnosis and treatment of IgE-mediated allergy in mammals. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020393408-A1 |
priorityDate |
2007-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |